Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 43 Leukemia, Myeloid, Acute 25 Recurrence 21 Lymphoma, Large B-Cell, Diffuse 12 Sarcoma 8 Neoplasms, Plasma Cell 5 Neoplasm Metastasis 5 Lymphoma 5 Glioblastoma 5 Ovarian Neoplasms 4 Neurofibrosarcoma 4 Neoplasms 4 Melanoma 4 Lymphoma, Non-Hodgkin 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2

Interventions

Docetaxel 277 Prednisone 236 enzalutamide 175 Leuprolide 172 Radiotherapy 164 Abiraterone Acetate 153 Magnetic Resonance Spectroscopy 147 bicalutamide 137 Goserelin 134 Androgen Antagonists 111 Radiosurgery 101 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100 apalutamide 78 abiraterone 75 gallium 68 PSMA-11 74 Specimen Handling 67 Gonadotropin-Releasing Hormone 58 darolutamide 56 Radiation 56 Triptorelin Pamoate 53 cabazitaxel 49 Zoledronic Acid 49 pembrolizumab 48 Radiotherapy, Intensity-Modulated 47 Flutamide 47 Brachytherapy 47 luprolide acetate gel depot 46 Standard of Care 45 Carboplatin 44 Estramustine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × selinexor × Clear all

NCT02146833 2023-01-26

SHIP

Karyopharm Therapeutics Inc

Phase 2 Terminated

20 enrolled 13 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡